INTERCEPT PHARMACEUTICALS, INC. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Option Exercise | A | 110.80 | 6,400 | 709,120 | 6,400 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Grant | A | 0.00 | 4,000 | 0 | 17,737 | 13.7 K to 17.7 K (+29.12 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Option Exercise | A | 110.80 | 6,800 | 753,440 | 6,800 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Grant | A | 0.00 | 4,200 | 0 | 19,804 | 15.6 K to 19.8 K (+26.92 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | A | 110.80 | 10,700 | 1,185,560 | 10,700 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Grant | A | 0.00 | 6,600 | 0 | 29,800 | 23.2 K to 29.8 K (+28.45 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | A | 110.80 | 5,300 | 587,240 | 5,300 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Grant | A | 0.00 | 3,300 | 0 | 40,543 | 37.2 K to 40.5 K (+8.86 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | A | 110.80 | 13,700 | 1,517,960 | 13,700 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Grant | A | 0.00 | 8,500 | 0 | 573,768 | 565.3 K to 573.8 K (+1.50 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Option Exercise | A | 110.80 | 7,200 | 797,760 | 7,200 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Grant | A | 0.00 | 4,500 | 0 | 27,923 | 23.4 K to 27.9 K (+19.21 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Option Exercise | A | 110.80 | 6,100 | 675,880 | 6,100 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Grant | A | 0.00 | 3,800 | 0 | 12,911 | 9.1 K to 12.9 K (+41.71 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Option Exercise | A | 110.80 | 15,200 | 1,684,160 | 15,200 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Grant | A | 0.00 | 9,400 | 0 | 34,365 | 25 K to 34.4 K (+37.65 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Option Exercise | A | 110.80 | 6,700 | 742,360 | 6,700 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Grant | A | 0.00 | 4,100 | 0 | 19,125 | 15 K to 19.1 K (+27.29 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Option Exercise | A | 110.80 | 5,300 | 587,240 | 5,300 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Grant | A | 0.00 | 3,300 | 0 | 22,107 | 18.8 K to 22.1 K (+17.55 %) |
| Jan 15 2019 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 109.73 | 77 | 8,449 | 13,737 | 13.8 K to 13.7 K (-0.56 %) |
| Jan 09 2019 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Sell | S | 104.93 | 1,313 | 137,773 | 18,807 | 20.1 K to 18.8 K (-6.53 %) |
| Jan 04 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 97.48 | 474 | 46,206 | 37,243 | 37.7 K to 37.2 K (-1.26 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 100.79 | 215 | 21,670 | 15,604 | 15.8 K to 15.6 K (-1.36 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 17,031 | |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 97.45 | 699 | 68,118 | 37,717 | 38.4 K to 37.7 K (-1.82 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 98.28 | 2,000 | 196,560 | 38,416 | 40.4 K to 38.4 K (-4.95 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 40,416 | 38.4 K to 40.4 K (+5.21 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 100.79 | 736 | 74,181 | 38,416 | 39.2 K to 38.4 K (-1.88 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 100.79 | 1,537 | 154,914 | 565,268 | 566.8 K to 565.3 K (-0.27 %) |